TP53 and gastric cancer: We classified the gastric cancer patients into 3 categories based on the p53 mutation status as well as the DNA methylation status of PGP9. 5, NMDAR2B and CCNA1, which we designated as genomic and epigenetic categories, respectively (GEC).